TickerFacts.

Zymeworks Inc. (ZYME): Share Repurchases

Annual figures by period end, from SEC filings.

$41.70M
Year ended 2025-12-31
$169.79M
Trailing 12 months to 2026-06-30
2022-12-31: $02023-12-31: $02024-12-31: $30.05M2025-12-31: $41.70M$41.70M
2022-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$41.70M+38.7%2026-03-02, From 2025-01-01
2024-12-31$30.05Mn/a2026-03-02, From 2024-01-01
2023-12-31$0n/a2026-03-02, From 2023-01-01
2022-12-31$0n/a2025-03-05, From 2022-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Zymeworks Inc. (ZYME)2025-12-31$41.70M+38.7%
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Theravance Biopharma, Inc. (TBPH)2024-12-31$445.0K-99.8%
Siga Technologies Inc (SIGA)2025-12-31$0n/a
Standard Biotools Inc. (LAB)2025-12-31$0-100.0%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Nektar Therapeutics (NKTR)2025-12-31$0-100.0%
Lexicon Pharmaceuticals, Inc. (LXRX)2024-12-31$1.73M+110.0%

Compare ZYME, ZVRA, TBPH, SIGA side by side · Screen every company in Pharmaceutical Preparations ↗